Type 1 diabetes is associated with autoimmunity to insulin. Genetic suscept
ibility to type 1 diabetes is polygenic and includes the INS VNTR-IDDM2 loc
us which may regulate the expression of insulin in pancreas and thymus. In
order to determine whether insulin autoimmunity could be attributed to a ge
netic susceptibility conferred by the INS VNTR-IDDM2 locus, peripheral bloo
d T cell proliferation to human insulin and insulin autoantibodies (IAA) wa
s measured in patients with new onset type 1 diabetes and control subjects.
IAA were detected in 21 of 53 patients and in none of 25 control subjects,
while T cell responses were low (stimulation index range 0.4-7.2) and simi
lar in both groups. Both antibody and T cell responses were higher in young
er subjects and IAA were more prevalent in patients with the HLA-DR4 allele
. No relationship was observed between humoral and cellular responses to in
sulin. No association was found between the INS VNTR-IDDM2-susceptible alle
le and insulin autoimmunity. Increased T cell responses and IAA were found
in patients with either the diabetes-susceptible or the diabetes-protective
INS VNTR-IDDM2 locus genotypes, and increased T cell responses were also f
ound in control subjects with either susceptible or protective INS VNTR-IDD
M2 locus genotypes. This study confirms that primary T cell proliferative r
esponses to insulin are low and detectable also in control subjects. The de
tection of T cell proliferation and autoantibodies to insulin in subjects w
ith and without the protective INS VNTR-IDDM2 locus genotypes does not supp
ort the hypothesis of an allele-specific capacity for tolerance induction w
hich could determine a susceptibility to develop autoimmunity against the i
nsulin protein and subsequently diabetes.